Ipsogen Board OKs Acquisition by Qiagen

Ipsogen's board has voted in favor of the deal, and shareholders holding 61 percent of Ipsogen's stock have agreed to sell their shares to Qiagen.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.